Chronic anemia and fatigue in elderly patients: Results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa

Journal of the American Geriatrics Society

Volumn 55, Issue 10, 2007, Pages 1557-1565

  Agnihotri, Parag ^a   Telfer, Margaret ^b,c   Butt, Zeeshan ^d,e   Jella, Abhay ^c   Cella, David ^d,e   Kozma, Chris M ^f   Ahuja, Mukesh ^c   Riaz, Shahbaz ^c   Akamah, Joseph ^b  

^a Mercy Medical Group   (United States)

^b John Stroger Hospital   (United States)

^c MICHAEL REESE HOSPITAL   (United States)

^d Research and Education   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Anemia; Elderly; Epoetin alfa; Fatigue

Indexed keywords

ASCORBIC ACID; FERROUS SULFATE; HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

AFRICAN AMERICAN; AGED; ANEMIA; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEEP VEIN THROMBOSIS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG FATALITY; DRUG TOLERABILITY; EDEMA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PATIENT MOBILITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STROKE; SYNCOPE; THORAX PAIN; VOMITING;

AGED; ANEMIA; CHICAGO; COMORBIDITY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPOETIN ALFA; FATIGUE; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MOBILITY LIMITATION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 34848837102     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01357.x     Document Type: Article

References (49)

1. Guralnik JM, Eisenstaedt RS, Ferrucci L et al. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 2004 104 : 2263 2268.
2. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005 352 : 1011 1023.
3. Means RT Jr., Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992 80 : 1639 1647.
4. Artz AS, Fergusson D, Drinka PJ et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc 2004 52 : 423 427.
5. Izaks GJ, Westendorp RG, Knook DL. The definition of anemia in older persons. JAMA 1999 281 : 1714 1717.
6. Chaves PH, Semba RD, Leng SX et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: The Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci 2005 60A : M729 M735.
7. Penninx BW, Pahor M, Woodman RC et al. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 2006 61A : M474 M479.
8. Penninx BW, Pahor M, Cesari M et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004 52 : 719 724.
9. Penninx BW, Guralnik JM, Onder G et al. Anemia and decline in physical performance among older persons. Am J Med 2003 115 : 104 110.
10. Zuccala G, Marzetti E, Cesari M et al. Correlates of cognitive impairment among patients with heart failure: Results of a multicenter survey. Am J Med 2005 118 : 496 502.
11. Weiskopf RB, Toy P, Hopf HW et al. Acute isovolemic anemia impairs central processing as determined by P300 latency. Clin Neurophysiol 2005 116 : 1028 1032.
12. Cella D, Lai JS, Chang CH et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002 94 : 528 538.
13. Jones M, Schenkel B, Just J et al. Epoetin alfa improves quality of life in patients with cancer: Results of metaanalysis. Cancer 2004 101 : 1720 1732.
14. Cella D. Factors influencing quality of life in cancer patients: Anemia and fatigue. Semin Oncol 1998 25 : 43 46.
15. Revicki DA, Brown RE, Feeny DH et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 1995 25 : 548 554.
16. Valderrabano F. Quality of life benefits of early anaemia treatment. Nephrol Dial Transplant 2000 15 (Suppl 3) : 23 28.
17. Kaltwasser JP, Kessler U, Gottschalk R et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol 2001 28 : 2430 2436.
18. Chaves PH, Ashar B, Guralnik JM et al. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc 2002 50 : 1257 1264.
19. Cella D, Zagari MJ, Vandoros C et al. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 2003 21 : 366 373.
20. Ershler WB, Artz AS, Kandahari MM. Recombinant erythropoietin treatment of anemia in older adults. J Am Geriatr Soc 2001 49 : 1396 1397.
21. Cella D, Dobrez D, Glaspy J. Control of cancer-related anemia with erythropoietic agents: A review of evidence for improved quality of life and clinical outcomes. Ann Oncol 2003 14 : 511 519.
22. Demetri GD, Kris M, Wade J et al. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998 16 : 3412 3425.
23. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev 2002 16 : 87 96.
24. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Properties, applications, and interpretation. Health Qual Life Outcomes 2003 1 : 79.
25. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 1997 34 : 13 19.
26. Cella D, Yount S, Sorensen M et al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005 32 : 811 819.
27. Cella D, Eton DT, Lai JS et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002 24 : 547 561.
28. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: A critical review. Psychol Med 1988 18 : 1007 1019.
29. Podsiadlo D, Richardson S. The timed "Up & Go": A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991 39 : 142 148.
30. Yellen SB, Cella DF, Webster K et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997 13 : 63 74.
31. Jacobs A, Worwood M. Ferritin in serum. Clinical and biochemical implications. N Engl J Med 1975 292 : 951 956.
32. Guyatt GH, Oxman AD, Ali M et al. Laboratory diagnosis of iron-deficiency anemia: An overview. J Gen Intern Med 1992 7 : 145 153.
33. National Kidney Foundation About CKD [on-line]. Available at Accessed January 10, 2007.
34. Cartwright GE. The anemia of chronic disorders. Semin Hematol 1966 3 : 351 375.
35. Wians FH Jr., Urban JE, Keffer JH et al. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration. Am J Clin Pathol 2001 115 : 112 118.
36. Gerard E., Dallal GE. Randomization.com [on-line]. Available at Accessed January 10, 2007.
37. Oakes JM, Feldman HA. Statistical power for non-equivalent pretest-posttest designs: The impact of change-score versus ANCOVA models. Eval Rev 2001 25 : 3 28.
38. Guralnik JM, Simonsick EM, Ferrucci L et al. A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994 49 : M85 M94.
39. Guyatt GH, Sullivan MJ, Thompson PJ et al. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985 132 : 919 923.
40. Guralnik JM, Ferrucci L, Simonsick EM et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995 332 : 556 561.
41. Guralnik JM, Ferrucci L, Pieper CF et al. Lower extremity function and subsequent disability: Consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000 55A : M221 M231.
42. Bittner V, Weiner DH, Yusuf S et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993 270 : 1702 1707.
43. Wun T, Law L, Harvey D et al. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 2003 98 : 1514 1520.
44. Rosenzweig MQ, Bender CM, Lucke JP et al. The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. J Pain Symptom Manage 2004 27 : 185 190.
45. FDA Healthcare Professional Sheet Regarding Evolving Safety Issues with ESAs [on-line]. Available at Accessed May 17, 2007.
46. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification [on-line]. Available at Accessed January 10, 2007.
47. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: A quantitative measure of tissue iron deficiency. Blood 1990 75 : 1870 1876.
48. Elis A, Ravid M, Manor Y et al. A clinical approach to "idiopathic" normocytic-normochromic anemia. J Am Geriatr Soc 1996 44 : 832 834.
49. Nilsson-Ehle H, Jagenburg R, Landahl S et al. Haematological abnormalities and reference intervals in the elderly. A cross-sectional comparative study of three urban Swedish population samples aged 70, 75 and 81 years. Acta Med Scand 1988 224 : 595 604.